Ying Tang

Efficacy, Safety, and Pharmacoeconomic Evaluation of Shiwei Longdanhua Capsules in Acute Exacerbation of Chronic Bronchitis with Phlegm-Heat Obstructing Fei (Lung): A Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Control Trial

Yunhui Li, Fan Yang, Ji-hong Feng, Shan-Jun Yang et autres

cn, gr (code pays fourni par la source)

Eye-tracking phenotypes reveal clinically meaningful heterogeneity of attention and executive control dysfunction after stroke

Xiao Fei, Ying Tang, Yue Shi, Yu Zhang

BACKGROUND: Post-stroke impairments in attention and executive control are common and clinically relevant, whereas conventional neuropsychological tests mainly capture task outcomes and provide limited information about process-level task behavior. Eye tracking can quantify fixation behavior, saccadic activity, and visual sampling, but whether …

cn (code pays fourni par la source)

Efficacy and safety of local treatments combined with targeted therapy and immunotherapy versus targeted therapy plus immunotherapy alone in hepatocellular carcinoma: A meta-analysis

Shaohua Zhang, Ying Tang, Xinbo Mao, Tao Sheng

BACKGROUND: Beyond surgical intervention, hepatocellular carcinoma is mainly treated with 3 main approaches: transarterial chemoembolization (TACE) or hepatic arterial infusion chemotherapy (HAIC) as local treatment, immune checkpoint inhibitors (ICIs), and tyrosine kinase inhibitors (TKIs). Up to now, clinical experts have not reached …

cn (code pays fourni par la source)

Comparative efficacy of focused ultrasound on hR-HPV clearance in premenopausal versus postmenopausal women: a retrospective cohort study

Ming‐tao Yang, Jun-rong Huang, Ying Tang, Huiquan Hu et autres

Objective This study focused on determining the clearance rate of high-risk human papillomavirus (HR-HPV) with chronic cervicitis or squamous intraepithelial lesion following focused ultrasound (FUS) in premenopausal and postmenopausal women.Methods From March 2022 to December 2024, clinicopathological data of 124 women, including …

cn (code pays fourni par la source)

Interleukin-6: A Potential Biomarker for Dysmenorrhea and Disease Severity in Adenomyosis

Ying Tang, Bin Su, Hongbo He, Xin Cai et autres

cn (code pays fourni par la source)

Comparison of Patterns of Locoregional Recurrence in Total Neoadjuvant Therapy vs. Chemoradiotherapy for Locally Advanced Rectal Cancer in the STELLAR Study

Jianwei Shuai, Tingting Xu, Li He, Heng Ma et autres

Two Cycles of Chemotherapy Modulate Itaconic Acid Levels via ATF3/TET2/NF-κB Pathways in Ovarian Cancer Among Han Chinese Women

Ying Tang, Jia En Wu, Qin Wang, Liya Sun et autres

cn (code pays fourni par la source)

Camrelizumab Plus Famitinib versus Camrelizumab Alone and Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer: A Randomized, Phase II Study

Lingfang Xia, Keqiang Zhang, Ying Tang, Guonan Zhang et autres

PURPOSE: To compare camrelizumab (an anti-PD-1 monoclonal antibody) plus famitinib (a multitarget receptor tyrosine kinase inhibitor) versus camrelizumab and chemotherapy in recurrent or metastatic cervical cancer (R/M CC). METHODS: Patients with pretreated R/M CC were randomly assigned to receive camrelizumab (200 mg …

cn, hk (code pays fourni par la source)

Investigating the relationship between visual impairment and cognitive impairment in the older adults using the novel vision screening assessment (VISA) tool

Ying Tang, Ya Wang, Xiao Fei, Xiaoyan Xu et autres

BackgroundEarly identification and multimodal treatment of dementia, especially Alzheimer's disease, is a common goal of global efforts.ObjectiveThis study aims to investigate the relationship between visual impairment (VI) and cognitive impairment in older adults using the Vision Screening Assessment (VISA) tool.MethodsA total of …

cn (code pays fourni par la source)

Cadonilimab plus platinum-based chemotherapy ± bevacizumab for persistent, recurrent, or metastatic cervical cancer: Subgroup analyses of COMPASSION-16.

Yang Sun, Hongying Yang, Hanmei Lou, Jing Wang et autres

5509 Background: The phase 3 COMPASSION-16 trial demonstrated statistically significant progression-free survival (PFS) and overall survival (OS) benefits with cadonilimab plus chemotherapy ± bevacizumab in patients with persistent, recurrent, or metastatic cervical cancer (R/M CC). This analysis assessed efficacy in several key …

cn (code pays fourni par la source)

Cesarean section diverticulum area predicting the intraoperative hemorrhage at suction curettage for cesarean scar pregnancy after focused ultrasound ablation surgery

Jun-rong Huang, Liya Sun, Ying Tang, Ming‐bo Wen et autres

Objectives To investigate the significance of the cesarean section diverticulum (CSD) area for predicting the intraoperative massive hemorrhage during suction curettage for cesarean scar pregnancy (CSP) after focused ultrasound ablation surgery (FUAS).Methods Data from 90 patients undergoing suction curettage after FUAS were …

cn (code pays fourni par la source)

IBI310 plus sintilimab vs. placebo plus sintilimab in recurrent/metastatic cervical cancer: A double-blind, randomized controlled trial

Huayi Li, Yancheng Xu, Xiaofei Jiao, Xu Qin et autres

BACKGROUND: It remains unclear whether adding CTLA-4 blockade to PD-1/PD-L1 blockade improves clinical outcomes in cervical cancer (CC). METHODS: In this randomized, double-blind, placebo-controlled, phase 2 study (ClinicalTrials.gov: NCT04590599), patients with recurrent/metastatic CC (R/M CC) who experienced disease progression after or during …

cn, hk, us, Éthiopie (code pays fourni par la source)